Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Braga

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2023
Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam TreatmentMarcio De Araujo Furtado, Vassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, et al.
Experimental Neurology|August 3, 2025
Sex-dependent differences in the antiseizure and neuroprotective effects of midazolam after soman exposure: Superior, sex-independent efficacy of tezampanel and caramiphenTaiza H Figueiredo, Vassiliki Aroniadou-Anderjaska, Volodymyr I Pidoplichko, et al.
British Journal of Pharmacology|April 14, 2011
Neuroprotective efficacy of caramiphen against soman and mechanisms of its actionT H Figueiredo, V Aroniadou-Anderjaska, F Qashu, et al.
Annals of the New York Academy of Sciences|March 23, 2016
Long-term neuropathological and behavioral impairments after exposure to nerve agentsVassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, James P Apland, et al.
Molecular Neurobiology|August 28, 2017
Alpha-Linolenic Acid Treatment Reduces the Contusion and Prevents the Development of Anxiety-Like Behavior Induced by a Mild Traumatic Brain Injury in RatsTaiza H Figueiredo, Carolina L Harbert, Volodymyr Pidoplichko, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxietyVolodymyr I Pidoplichko, Vassiliki Aroniadou-Anderjaska, Eric M Prager, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral AmygdalaSteven L Miller, Vassiliki Aroniadou-Anderjaska, Volodymyr I Pidoplichko, et al.
Toxicology and Applied Pharmacology|February 18, 2015
A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonistsSteven L Miller, Vassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, et al.
Experimental Neurology|August 5, 2015
GABAergic interneuronal loss and reduced inhibitory synaptic transmission in the hippocampal CA1 region after mild traumatic brain injuryCamila P Almeida-Suhett, Eric M Prager, Volodymyr Pidoplichko, et al.
Plos One|July 23, 2014
Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injuryCamila P Almeida-Suhett, Eric M Prager, Volodymyr Pidoplichko, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2023
Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam TreatmentMarcio De Araujo Furtado, Vassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, et al.
Experimental Neurology|August 3, 2025
Sex-dependent differences in the antiseizure and neuroprotective effects of midazolam after soman exposure: Superior, sex-independent efficacy of tezampanel and caramiphenTaiza H Figueiredo, Vassiliki Aroniadou-Anderjaska, Volodymyr I Pidoplichko, et al.
British Journal of Pharmacology|April 14, 2011
Neuroprotective efficacy of caramiphen against soman and mechanisms of its actionT H Figueiredo, V Aroniadou-Anderjaska, F Qashu, et al.
Annals of the New York Academy of Sciences|March 23, 2016
Long-term neuropathological and behavioral impairments after exposure to nerve agentsVassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, James P Apland, et al.
Molecular Neurobiology|August 28, 2017
Alpha-Linolenic Acid Treatment Reduces the Contusion and Prevents the Development of Anxiety-Like Behavior Induced by a Mild Traumatic Brain Injury in RatsTaiza H Figueiredo, Carolina L Harbert, Volodymyr Pidoplichko, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxietyVolodymyr I Pidoplichko, Vassiliki Aroniadou-Anderjaska, Eric M Prager, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral AmygdalaSteven L Miller, Vassiliki Aroniadou-Anderjaska, Volodymyr I Pidoplichko, et al.
Toxicology and Applied Pharmacology|February 18, 2015
A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonistsSteven L Miller, Vassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, et al.
Experimental Neurology|August 5, 2015
GABAergic interneuronal loss and reduced inhibitory synaptic transmission in the hippocampal CA1 region after mild traumatic brain injuryCamila P Almeida-Suhett, Eric M Prager, Volodymyr Pidoplichko, et al.
Plos One|July 23, 2014
Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injuryCamila P Almeida-Suhett, Eric M Prager, Volodymyr Pidoplichko, et al.
Pageof 8